top of page
The Role of Immunotherapy in the Management of Late Stage NSCLC and the Role of the Multidisciplinary Tumor Board
CHEST
9/16/20, 5:00 PM
America/Chicago UTC -5
Description
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Eric Edell
Describe the latest evidence and best practice in the use of immunotherapy in treating NSCLC, Describe effective multidisciplinary case management of patients with NSCLC who may benefit from immunotherapy
Inglês
Description
Speakers
Narjust Duma, Julian Molina
Speakers
Link to Event
Banner
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.
Registro
bottom of page